Delivery Order SPE2DB20D2014-SPE2DB24FA85S
Award Date
1/22/24
Potential Completion Date
1/23/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $31,267.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of HEMABATE 250 MCG/ML AMPULML, with a completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,646.59, is for the delivery of HEMABATE 250 MCG/ML AMPULML, a medication used in healthcare settings. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $33,409.40 fixed-price delivery order is for the supply of Hemlibra 150 mg/mL vials, a specialty pharmaceutical product. The contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This federal contract award, valued at $10,375.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with...
The U.S. government has awarded a delivery order contract worth $7,673.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical and medical products to support the Medical Supply Chain of the Defense agency. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,336.54 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,224.98 and covers the delivery of 2,400 units of HUMATE-P, a medication used to treat von Willebrand disease. The contract is a firm fixed-price delivery order with a completion date of March 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Hemlibra 150 mg/mL, which was awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $16,704.72 and a period of performance through July 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award is for Amerisourcebergen Drug Corp's Corporate Office Division to supply the Defense Logistics Agency (DLA) with pharmaceutical products and medical supplies. The contract, valued at up to $4,679.31, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The specific items being delivered are 4564339522 - BARHEMSYS 10 MG/4 ML...
This federal contract award, valued at $12,990.43, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which runs through April 30, 2024, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...